Cell cycle deregulation in B-cell lymphomas

M Sánchez-Beato… - Blood, The Journal of …, 2003 - ashpublications.org
Disruption of the physiologic balance between cell proliferation and death is a universal
feature of all cancers. In general terms, human B-cell lymphomas can be subdivided into 2 …

POZ for effect–POZ-ZF transcription factors in cancer and development

KF Kelly, JM Daniel - Trends in cell biology, 2006 - cell.com
The BTB/POZ-ZF [Broad complex, Tramtrack, Bric à brac (BTB) or poxvirus and zinc finger
(POZ)-zinc finger] protein family comprises a diverse group of transcription factors. POZ-ZF …

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

WK Kelly, OA O'Connor, LM Krug, JH Chiao… - Journal of clinical …, 2005 - ascopubs.org
Purpose To determine the safety, dosing schedules, pharmacokinetic profile, and biologic
effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid …

Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma

L Pasqualucci, A Migliazza, K Basso… - Blood, The Journal …, 2003 - ashpublications.org
The BCL6 proto-oncogene encodes a transcriptional repressor whose expression is
deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell …

Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets

MD Gearhart, CM Corcoran, JA Wamstad… - … and cellular biology, 2006 - Am Soc Microbiol
The corepressor BCOR potentiates transcriptional repression by the proto-oncoprotein
BCL6 and suppresses the transcriptional activity of a common mixed-lineage leukemia …

Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain

KF Ahmad, A Melnick, S Lax, D Bouchard, J Liu… - Molecular cell, 2003 - cell.com
BCL6 encodes a transcription factor that represses genes necessary for the terminal
differentiation of lymphocytes within germinal centers, and the misregulated expression of …

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced …

OA O'Connor, ML Heaney, L Schwartz… - Journal of Clinical …, 2006 - ascopubs.org
Purpose To document the toxicity and activity of the histone deacetylase inhibitor
suberoylanilide hydroxamic acid (SAHA) in patients with pretreated hematologic …

The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis

Y Miyauchi, K Ninomiya, H Miyamoto… - Journal of Experimental …, 2010 - rupress.org
Controlling osteoclastogenesis is critical to maintain physiological bone homeostasis and
prevent skeletal disorders. Although signaling activating nuclear factor of activated T cells 1 …

Bone mesenchymal stem cell secretion of sRANKL/OPG/M-CSF in response to macrophage-mediated inflammatory response influences osteogenesis on …

Q Ma, L Fang, N Jiang, L Zhang, Y Wang, Y Zhang… - Biomaterials, 2018 - Elsevier
Although it has been well established that osteogenic differentiation of bone mesenchymal
stem cells (bMSCs) as well as osteoclastic differentiation of macrophages can be …

Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 …

K Brocke-Heidrich, AK Kretzschmar, G Pfeifer, C Henze… - Blood, 2004 - ashpublications.org
Abstract Interleukin 6 (IL-6) is a growth and survival factor for multiple myeloma cells. As we
report here, the IL-6–dependent human myeloma cell line INA-6 responds with a remarkably …